CD8A and neoplasm: FMD potentiates the cytotoxic effect of chemotherapy and increases the immune infiltrate in breast and melanoma cancer by reducing tumor HO-1 expression, a potent immunomodulator involved in suppressing CD8+ T-cells infiltration and cytotoxic activity and promoting Treg accumulation [272].